electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6
Domestic: 877-269-7756
International: 201-689-7817
Conference ID: 13718262
Webcast: electroCore 1Q21 Business Update Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:Rich Cockrell CG Capital 404-736-3838 ecor@cg.capital or Media Contact:Summer Diaz electroCore 816-401-6333 summer.diaz@electrocore.com